US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MetaVia Inc

1.79

-0.0300-1.65%

Post-market: 1.840.0500+2.79%19:53 EST

Volume:121.74K

Turnover:222.53K

Market Cap:5.74M

PE:-0.16

High:1.89

Open:1.84

Low:1.78

Close:1.82

52wk High:23.10

52wk Low:1.66

Shares:3.21M

Float Shares:2.29M

Volume Ratio:0.28

T/O Rate:5.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-11.3639

EPS(LYR):-39.1268

ROE:-168.18%

ROA:-58.41%

PB:0.91

PE(LYR):-0.05

Loading ...

Overview Company News Filings

BRIEF-Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel

Metavia Collaborates with Syntekabio on AI-Driven Drug Discovery

Metavia Inc. Discloses 2025 Executive Bonus and Compensation Figures

MetaVia Inc trading halted, volatility trading pause

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

Metavia Announces the Pricing of $8.1 Million Underwritten Public Offering

THOMSON REUTERS

MetaVia Is Maintained at Buy by HC Wainwright & Co.

Metavia Inc. Unveils Pipeline Advancements Targeting Obesity and MASH

BRIEF-Metavia Reports Positive Statistically Significant Results From Its Phase 1B Clinical Trial Of Da-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss And Favorable Safety Profile

Metavia Inc. Reports Phase 1b Trial Success for DA-1726 in Obesity and Metabolic Disease

Metavia Inc - 12.3 Mg/Dl Fasted Glucose Reduction by Day 54 in Study

THOMSON REUTERS

MetaVia Inc. to Sponsor and Participate in 10th Annual MASH-TAG Conference

BRIEF-Metavia Regains Compliance With Nasdaq Minimum Bid Price Requirement

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:56 AM

MetaVia to Implement 1-for-11 Reverse Stock Split

MT Newswires Live

BRIEF-Metavia Inc. Announces 1-For-11 Reverse Stock Split

Metavia Inc. Faces Nasdaq Delisting Risk Over $1 Minimum Bid Price Requirement

Metavia Reports Positive Phase 2a Results for Vanoglipel in MASH Patients

Metavia Inc. Unveils Pipeline Advances Targeting Obesity and MASH

MetaVia Q3 EPS $(0.14) Beats $(0.25) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTVA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":1.79,"timestamp":1770670800000,"preClose":1.82,"halted":0,"volume":121735,"hourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.79,"latestTime":"19:53 EST","volume":2018,"amount":3705.9576,"timestamp":1770684817009,"change":0.05,"changeRate":0.027933,"amplitude":0.03352},"delay":0,"changeRate":-0.016483516483516498,"floatShares":2288400,"shares":3208200,"eps":-11.363935,"marketStatus":"Closed","change":-0.03,"latestTime":"02-09 16:00:00 EST","open":1.84,"high":1.89,"low":1.7807,"amount":222533.1747285,"amplitude":0.060055,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.363935,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":1.82,"preHourTrading":{"tag":"盘前","latestPrice":1.83,"preClose":1.82,"latestTime":"09:29 EST","volume":2829,"amount":5244.6483033,"timestamp":1770647376049,"change":0.01,"changeRate":0.005495,"amplitude":0.050165},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.79,"latestTime":"19:53 EST","volume":2018,"amount":3705.9576,"timestamp":1770684817009,"change":0.05,"changeRate":0.027933,"amplitude":0.03352},"volumeRatio":0.277761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":2288400,"roa":"-58.41%","roe":"-168.18%","lyrEps":-39.126846,"volumeRatio":0.277761,"shares":3208200,"dividePrice":0,"high":1.89,"amplitude":0.060055,"preClose":1.82,"low":1.7807,"week52Low":1.6608,"pbRate":"0.91","week52High":23.1,"institutionHeld":0,"latestPrice":1.79,"eps":-11.363935,"divideRate":0,"volume":121735,"delay":0,"ttmEps":-11.363935,"open":1.84,"prevYearClose":8.42,"prevWeekClose":1.82,"prevMonthClose":2.43,"prevQuarterClose":8.42,"fiveDayClose":2.31,"twentyDayClose":8.155,"sixtyDayClose":8.4381},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-05","symbol":"MTVA","defaultRemindTime":1764945000000,"type":"split","dateTimestamp":1764910800000,"forFactor":11,"toFactor":1,"ratio":11},{"market":"US","date":"2025-11-06","symbol":"MTVA","fiscalQuarterEnding":"2025/09","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-08-07","symbol":"MTVA","fiscalQuarterEnding":"2025/06","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-05-14","symbol":"MTVA","fiscalQuarterEnding":"2025/03","expectedEps":-0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.36},{"date":"2025-03-20","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742457600000,"name":null,"time":"Pre-Market","dateTimestamp":1742443200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735794000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2026-02-06","current":-0.157516,"percent":0.905085,"low":-1.962939,"twenty":-1.143026,"median":-0.58718,"eighty":-0.483057,"high":-0.203888,"avg":-0.741857,"sd":0.354935,"marketCap":5550210},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270},{"date":"2025-04-25","current":-0.266622,"twenty":-0.631917,"median":-0.512617,"eighty":-0.463425,"marketCap":7356638},{"date":"2025-05-02","current":-0.239019,"twenty":-0.626947,"median":-0.506404,"eighty":-0.454331,"marketCap":6595010},{"date":"2025-05-09","current":-0.222708,"twenty":-0.618869,"median":-0.49874,"eighty":-0.452346,"marketCap":6144956},{"date":"2025-05-16","current":-0.238257,"twenty":-0.615141,"median":-0.497083,"eighty":-0.429105,"marketCap":5848960},{"date":"2025-05-23","current":-0.285534,"twenty":-0.611413,"median":-0.49458,"eighty":-0.263184,"marketCap":7009578},{"date":"2025-05-30","current":-0.543676,"twenty":-0.612655,"median":-0.49689,"eighty":-0.271352,"marketCap":13346706},{"date":"2025-06-06","current":-0.549972,"twenty":-0.608927,"median":-0.497673,"eighty":-0.281282,"marketCap":13501264},{"date":"2025-06-13","current":-0.597709,"twenty":-0.608927,"median":-0.503297,"eighty":-0.294785,"marketCap":14673160},{"date":"2025-06-20","current":-0.557862,"twenty":-0.607995,"median":-0.509511,"eighty":-0.332562,"marketCap":13694949},{"date":"2025-06-27","current":-0.542591,"twenty":-0.603956,"median":-0.515396,"eighty":-0.428478,"marketCap":13320078},{"date":"2025-07-03","current":-0.516978,"twenty":-0.602714,"median":-0.515103,"eighty":-0.429732,"marketCap":12691292},{"date":"2025-07-11","current":-0.572913,"twenty":-0.599701,"median":-0.516978,"eighty":-0.432869,"marketCap":14064436},{"date":"2025-07-18","current":-0.535431,"twenty":-0.597709,"median":-0.518414,"eighty":-0.439456,"marketCap":13144307},{"date":"2025-07-25","current":-0.587857,"twenty":-0.5965,"median":-0.521601,"eighty":-0.450482,"marketCap":14431313},{"date":"2025-08-01","current":-0.482926,"twenty":-0.587857,"median":-0.520838,"eighty":-0.453589,"marketCap":11855342},{"date":"2025-08-08","current":-0.674088,"twenty":-0.587857,"median":-0.518654,"eighty":-0.453589,"marketCap":12464564},{"date":"2025-08-15","current":-0.837521,"twenty":-0.602714,"median":-0.525504,"eighty":-0.453589,"marketCap":15486597},{"date":"2025-08-22","current":-0.836212,"twenty":-0.615141,"median":-0.534692,"eighty":-0.453589,"marketCap":15462399},{"date":"2025-08-29","current":-0.846681,"twenty":-0.624461,"median":-0.53558,"eighty":-0.454826,"marketCap":15655982},{"date":"2025-09-05","current":-0.898895,"twenty":-0.643102,"median":-0.537471,"eighty":-0.457336,"marketCap":16621475},{"date":"2025-09-12","current":-0.894708,"twenty":-0.675347,"median":-0.537746,"eighty":-0.459434,"marketCap":16544042},{"date":"2025-09-19","current":-1.200403,"twenty":-0.704615,"median":-0.540578,"eighty":-0.459802,"marketCap":22196650},{"date":"2025-09-26","current":-1.308626,"twenty":-0.720771,"median":-0.542033,"eighty":-0.464632,"marketCap":24197809},{"date":"2025-10-03","current":-1.285464,"twenty":-0.777314,"median":-0.543184,"eighty":-0.467223,"marketCap":23769507},{"date":"2025-10-10","current":-1.347885,"twenty":-0.814044,"median":-0.546792,"eighty":-0.468812,"marketCap":24923743},{"date":"2025-10-17","current":-1.360971,"twenty":-0.829721,"median":-0.548697,"eighty":-0.471608,"marketCap":25165721},{"date":"2025-10-24","current":-1.257721,"twenty":-0.836474,"median":-0.551486,"eighty":-0.475169,"marketCap":23256514},{"date":"2025-10-31","current":-1.275649,"twenty":-0.839353,"median":-0.556987,"eighty":-0.478202,"marketCap":23588024},{"date":"2025-11-07","current":-1.112332,"twenty":-0.856339,"median":-0.562326,"eighty":-0.479691,"marketCap":20568137},{"date":"2025-11-14","current":-0.985555,"twenty":-0.895545,"median":-0.562464,"eighty":-0.481224,"marketCap":15981760},{"date":"2025-11-21","current":-0.990035,"twenty":-0.925649,"median":-0.572913,"eighty":-0.482587,"marketCap":16054404},{"date":"2025-11-28","current":-1.16176,"twenty":-1.03994,"median":-0.573323,"eighty":-0.482894,"marketCap":18839105},{"date":"2025-12-05","current":-0.993021,"twenty":-1.048481,"median":-0.575956,"eighty":-0.483005,"marketCap":16102829},{"date":"2025-12-12","current":-1.162032,"twenty":-1.114901,"median":-0.581053,"eighty":-0.483057,"marketCap":18843504},{"date":"2025-12-19","current":-1.126736,"twenty":-1.121412,"median":-0.584073,"eighty":-0.483629,"marketCap":18271155},{"date":"2025-12-26","current":-1.324933,"twenty":-1.135751,"median":-0.58567,"eighty":-0.484268,"marketCap":21485117},{"date":"2026-01-02","current":-1.143026,"twenty":-1.158344,"median":-0.587519,"eighty":-0.484763,"marketCap":18535316},{"date":"2026-01-09","current":-1.138004,"twenty":-1.161978,"median":-0.597709,"eighty":-0.485344,"marketCap":18453866},{"date":"2026-01-16","current":-0.447979,"twenty":-1.16176,"median":-0.601208,"eighty":-0.485344,"marketCap":7264435},{"date":"2026-01-23","current":-0.551981,"twenty":-1.16176,"median":-0.598705,"eighty":-0.485958,"marketCap":8950917},{"date":"2026-01-30","current":-0.466908,"twenty":-1.144681,"median":-0.593528,"eighty":-0.48519,"marketCap":7571385},{"date":"2026-02-06","current":-0.342268,"twenty":-1.143026,"median":-0.58718,"eighty":-0.483057,"marketCap":5550210}],"updateTime":1770694287491},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTVA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608364903","title":"BRIEF-Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364903","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364903?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:06","pubTimestamp":1770210402,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Inc - Announces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For VanoglipelFeb 4 (Reuters) - SyntekaBio Inc 226330.KQ:METAVIA IN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nFWN3Z01JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2608364645","title":"Metavia Collaborates with Syntekabio on AI-Driven Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2608364645","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608364645?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:02","pubTimestamp":1770210150,"startTime":"0","endTime":"0","summary":"Metavia Inc., a clinical-stage biotechnology company specializing in cardiometabolic diseases, has announced positive results from its ongoing collaboration with Syntekabio, Inc., an AI-driven drug discovery company. The partnership leverages Syntekabio’s proprietary DeepMatcher platform to confirm key therapeutic targets for Metavia’s candidate Vanoglipel. The AI-modeling results demonstrated strong inflammatory and cardiometabolic target engagement, supporting the further development of Vanoglipel for conditions such as MASH and potentially type 2 diabetes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire  on February 04, 2026, and is solely re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL4sWrKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2606730088","title":"Metavia Inc. Discloses 2025 Executive Bonus and Compensation Figures","url":"https://stock-news.laohu8.com/highlight/detail?id=2606730088","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606730088?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:02","pubTimestamp":1769547738,"startTime":"0","endTime":"0","summary":"Metavia Inc. has announced updated compensation details for its principal executive officers for the fiscal year 2025. The Compensation Committee approved discretionary cash bonuses for the Named Executive Officers, including President and Chief Executive Officer Hyung Heon Kim, who will receive a salary of $479,723, a bonus of $239,862, and other compensation totaling $36,743, bringing his total compensation for 2025 to $756,328. Chief Financial Officer Marshall H. Woodworth will receive a salary of $393,300, a bonus of $157,320, and other compensation of $12,365, with his total compensation amounting to $562,985 for 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL4V01xP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2603898690","title":"MetaVia Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2603898690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603898690?lang=en_us&edition=fundamental","pubTime":"2026-01-15 22:35","pubTimestamp":1768487722,"startTime":"0","endTime":"0","summary":"09:33 EST MetaVia (MTVA) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metavia-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metavia-inc-trading-halted-volatility-trading-pause-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2603986590","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2603986590","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603986590?lang=en_us&edition=fundamental","pubTime":"2026-01-15 22:33","pubTimestamp":1768487605,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:33 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nAQN2LHT8L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2603998635","title":"Metavia Announces the Pricing of $8.1 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2603998635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603998635?lang=en_us&edition=fundamental","pubTime":"2026-01-15 22:32","pubTimestamp":1768487573,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nTUA2TRGNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2601812800","title":"MetaVia Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812800","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601812800?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:05","pubTimestamp":1767722700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MTVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2026 13:05 ET (18:05 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2601892160","title":"Metavia Inc. Unveils Pipeline Advancements Targeting Obesity and MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2601892160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601892160?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:39","pubTimestamp":1767703199,"startTime":"0","endTime":"0","summary":"Metavia Inc. , a clinical-stage biotechnology company, has released a corporate presentation detailing its focus on developing next-generation therapeutics targeting obesity and metabolic dysfunction-associated steatohepatitis . The presentation outlines the company’s product pipeline, including candidates such as Vanoglipel  and DA-1726, which are being advanced for cardiometabolic diseases. Key risks identified by Metavia include potential impacts from government agency funding, possible Nasdaq delisting, future strategic transactions, and challenges related to clinical trial outcomes and regulatory approvals. The company also highlights factors such as resource allocation, public perception of obesity treatments, and obligations under licensing agreements as potential risks. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and ti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL1mJhtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2601882112","title":"BRIEF-Metavia Reports Positive Statistically Significant Results From Its Phase 1B Clinical Trial Of Da-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss And Favorable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2601882112","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601882112?lang=en_us&edition=fundamental","pubTime":"2026-01-05 22:09","pubTimestamp":1767622182,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Reports Positive Statistically Significant Results From Its Phase 1B Clinical Trial Of Da-1726 In Metabolic Disease - Demonstrating Strong Glycemic Response, Significant Direct Hepatic E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA1CYWC6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2601366884","title":"Metavia Inc. Reports Phase 1b Trial Success for DA-1726 in Obesity and Metabolic Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2601366884","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601366884?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:31","pubTimestamp":1767619883,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire  on January 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL6lbvZs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2601884891","title":"Metavia Inc - 12.3 Mg/Dl Fasted Glucose Reduction by Day 54 in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2601884891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601884891?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:30","pubTimestamp":1767619801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nTUA1CYWC6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2595738124","title":"MetaVia Inc. to Sponsor and Participate in 10th Annual MASH-TAG Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2595738124","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595738124?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:31","pubTimestamp":1767015079,"startTime":"0","endTime":"0","summary":"MetaVia Inc. will participate in and sponsor the 10th Annual MASH-TAG 2026 Conference, taking place January 8-10 at the Chateaux Deer Valley in Park City, Utah. Members of MetaVia's business development and clinical teams are expected to attend the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via PR Newswire  on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL3zGxTj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2593438924","title":"BRIEF-Metavia Regains Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2593438924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593438924?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:45","pubTimestamp":1766411158,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Regains Compliance With Nasdaq Minimum Bid Price RequirementDec 22 (Reuters) - MetaVia Inc MTVA.O:METAVIA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTSource text: ID:nPn3bl5r6aFurther company coverage: MTVA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUA877HFG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2590231536","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:56 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2590231536","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590231536?lang=en_us&edition=fundamental","pubTime":"2025-12-10 23:56","pubTimestamp":1765382199,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:56 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nAQN2LD12N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2588511057","title":"MetaVia to Implement 1-for-11 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2588511057","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588511057?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:27","pubTimestamp":1764692878,"startTime":"0","endTime":"0","summary":"MetaVia  said Tuesday it will implement a 1-for-11 reverse stock split of its common stock.The split-adjusted shares will begin trading on the Nasdaq Capital Market on Friday and is intended to comply with Nasdaq's continued listing requirements, the company said.MetaVia said the reverse split will reduce the number of outstanding shares to 2.3 million from about 25.4 million.Shares of MetaVia fell over 17% in recent Tuesday trading.Price: 0.62, Change: -0.13, Percent Change: -17.40","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2588553056","title":"BRIEF-Metavia Inc. Announces 1-For-11 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2588553056","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588553056?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:45","pubTimestamp":1764683129,"startTime":"0","endTime":"0","summary":"BRIEF-Metavia Inc. Announces 1-For-11 Reverse Stock SplitDec 2 (Reuters) - MetaVia Inc MTVA.O:METAVIA INC. ANNOUNCES 1-FOR-11 REVERSE STOCK SPLITSource text: ID:nPn5GjtQcaFurther company coverage: MTVA.O ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA25X2ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2586298386","title":"Metavia Inc. Faces Nasdaq Delisting Risk Over $1 Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298386","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298386?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:30","pubTimestamp":1764192656,"startTime":"0","endTime":"0","summary":"Metavia Inc. is currently facing a regulatory issue related to its continued listing on the Nasdaq Capital Market. The company received notice from Nasdaq that it is not in compliance with the minimum bid price requirement, as its stock has traded below $1.00 for 30 consecutive trading days. Metavia has been granted a 180-day extension, until May 26, 2026, to regain compliance, which it plans to address by considering a reverse stock split if necessary. Failure to meet the requirement could result in the company's stock being delisted from Nasdaq.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Metavia Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL11y61P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"gpt_icon":0},{"id":"2581885386","title":"Metavia Reports Positive Phase 2a Results for Vanoglipel in MASH Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2581885386","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581885386?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:31","pubTimestamp":1762522279,"startTime":"0","endTime":"0","summary":"MetaVia Inc. has announced positive new data from its Phase 2a clinical trial evaluating vanoglipel , an oral GPR119 agonist, for the treatment of metabolic dysfunction-associated steatohepatitis . The results, which were presented at the American Association for the Study of Liver Diseases  The Liver Meeting 2025, demonstrated clinically meaningful reductions in HbA1c, improvements in liver inflammation and fibrosis, and favorable changes in plasma lipidomic profiles after 16 weeks of treatment. The data suggest vanoglipel's potential to address both hepatic and metabolic factors in MASH. The findings were shared during a poster presentation on November 10, 2025, and the poster is available on the MetaVia website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL5MWT6x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2581509622","title":"Metavia Inc. Unveils Pipeline Advances Targeting Obesity and MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2581509622","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581509622?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:44","pubTimestamp":1762436691,"startTime":"0","endTime":"0","summary":"Metavia Inc. has presented new clinical data on its pipeline targeting cardiometabolic diseases, including obesity and metabolic dysfunction-associated steatohepatitis . The company highlighted its lead candidate DA-1726, a novel GLP1R/GCGR dual agonist, which demonstrated weight loss of up to 6.3% and reductions in fasted glucose and waist circumference over a 26-33 day period in a Phase 1 study. The candidate was generally well-tolerated, with mild gastrointestinal events reported and no treatment-related discontinuations. Metavia also reported positive Phase 2a top-line data for Vanoglipel  in MASH, confirming primary endpoint achievement and a favorable safety profile. Additional dose-finding and longer-duration studies are ongoing. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated conten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL9qfHnV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2581096148","title":"MetaVia Q3 EPS $(0.14) Beats $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096148","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096148?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:41","pubTimestamp":1762436484,"startTime":"0","endTime":"0","summary":"MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.25) by 43.78 percent. This is a 74.55 percent increase over losses of $(0.55) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48685184/metavia-q3-eps-0-14-beats-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","TQQQ","USJW.SI","PSQ","QID","NVIW.SI","MNQmain",".IXIC","NQmain","SQQQ","TSYW.SI","BK4139","MTVA","USAW.SI"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}]}}